Alnylam Pharmaceuticals
ALNY
#443
Rank
A$79.95 B
Marketcap
A$605.23
Share price
1.06%
Change (1 day)
56.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company